PT1071702E - Derivados de acidos gordos de acidos biliares e derivados de acidos biliares - Google Patents

Derivados de acidos gordos de acidos biliares e derivados de acidos biliares

Info

Publication number
PT1071702E
PT1071702E PT99912026T PT99912026T PT1071702E PT 1071702 E PT1071702 E PT 1071702E PT 99912026 T PT99912026 T PT 99912026T PT 99912026 T PT99912026 T PT 99912026T PT 1071702 E PT1071702 E PT 1071702E
Authority
PT
Portugal
Prior art keywords
bile
acids
acid
derivatives
biliary
Prior art date
Application number
PT99912026T
Other languages
English (en)
Inventor
Tuvia Gilat
Original Assignee
Galmed Int Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Galmed Int Ltd filed Critical Galmed Int Ltd
Publication of PT1071702E publication Critical patent/PT1071702E/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J41/00Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J9/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J41/00Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0005Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring the nitrogen atom being directly linked to the cyclopenta(a)hydro phenanthrene skeleton

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Fats And Perfumes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PT99912026T 1998-04-08 1999-03-25 Derivados de acidos gordos de acidos biliares e derivados de acidos biliares PT1071702E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL12399898A IL123998A (en) 1998-04-08 1998-04-08 Conjugates of bile salts and pharmaceutical preparations containing them

Publications (1)

Publication Number Publication Date
PT1071702E true PT1071702E (pt) 2003-01-31

Family

ID=11071405

Family Applications (1)

Application Number Title Priority Date Filing Date
PT99912026T PT1071702E (pt) 1998-04-08 1999-03-25 Derivados de acidos gordos de acidos biliares e derivados de acidos biliares

Country Status (25)

Country Link
US (3) US6395722B1 (pt)
EP (1) EP1071702B1 (pt)
JP (1) JP5031942B2 (pt)
KR (1) KR100615560B1 (pt)
CN (1) CN100386339C (pt)
AT (1) ATE222923T1 (pt)
AU (1) AU742944B2 (pt)
BR (1) BRPI9909908B8 (pt)
CA (1) CA2325933C (pt)
CZ (1) CZ300824B6 (pt)
DE (1) DE69902647T2 (pt)
DK (1) DK1071702T3 (pt)
EA (1) EA003392B1 (pt)
ES (1) ES2183526T3 (pt)
HU (1) HU229513B1 (pt)
ID (1) ID26042A (pt)
IL (1) IL123998A (pt)
NO (1) NO316875B1 (pt)
NZ (1) NZ507309A (pt)
PL (1) PL199271B1 (pt)
PT (1) PT1071702E (pt)
SI (1) SI1071702T1 (pt)
TR (1) TR200002876T2 (pt)
UA (1) UA70318C2 (pt)
WO (1) WO1999052932A1 (pt)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL142650A (en) * 1998-04-08 2007-06-03 Galmed Int Ltd Use of bile acid conjugates or bile salts and fatty acids or fatty acids in the preparation of pharmaceuticals for lowering cholesterol, for the treatment of fatty liver and for the treatment of hyperglycemia and diabetes
IL123998A (en) * 1998-04-08 2004-09-27 Galmed Int Ltd Conjugates of bile salts and pharmaceutical preparations containing them
US20030083231A1 (en) * 1998-11-24 2003-05-01 Ahlem Clarence N. Blood cell deficiency treatment method
US8975246B2 (en) 2001-04-17 2015-03-10 Galmed Research And Development Ltd. Bile acid or bile salt fatty acid conjugates
US7053076B2 (en) 2001-08-29 2006-05-30 Xenoport, Inc. Bile-acid derived compounds for enhancing oral absorption and systemic bioavailability of drugs
ITMI20021025A1 (it) * 2002-05-14 2003-11-14 Nicox Sa Farmaci per il trattamento acuto di disfunzioni del circolo venoso epatico e portale
US20080026077A1 (en) * 2002-11-12 2008-01-31 John Hilfinger Methods and compositions of gene delivery agents for systemic and local therapy
US7906137B2 (en) * 2004-05-21 2011-03-15 Mediplex Corporation, Korea Delivery agents for enhancing mucosal absorption of therapeutic agents
US20090035348A1 (en) * 2005-11-22 2009-02-05 Z & Z Medical Holdings, Inc. Dissolution of arterial plaque
US8304383B2 (en) 2005-11-22 2012-11-06 Atheronova Operations, Inc. Dissolution of arterial plaque
WO2007084549A2 (en) * 2006-01-20 2007-07-26 Filiberto Zadini Drug-eluting stent with atherosclerotic plaques dissolving pharmacological preparation
US20070212470A1 (en) * 2006-03-13 2007-09-13 Nutracea Therapeutic uses of an anti-cancer composition derived from rice bran
US20080038385A1 (en) * 2006-03-13 2008-02-14 Nutracea Therapeutic uses of an anti-cancer composition derived from rice bran
US20090305943A1 (en) * 2006-07-18 2009-12-10 Sven Siegel Cyclodextrin blends with crystal growth inhibitors
AU2008242583B2 (en) 2007-04-23 2013-10-10 Alnylam Pharmaceuticals, Inc. Glycoconjugates of RNA interference agents
US20080287429A1 (en) * 2007-05-15 2008-11-20 Z & Z Medical Holdings, Inc. Dissolution of Arterial Cholesterol Plaques by Pharmacologically Induced Elevation of Endogenous Bile Salts
US20100311708A1 (en) * 2007-07-25 2010-12-09 Tarek Moustafa Use of nor-bile acids in the treatment of arteriosclerosis
CN101367859B (zh) * 2007-08-17 2011-05-11 中国人民解放军军事医学科学院毒物药物研究所 脂肪酸胆汁酸偶合物及其医药用途
CZ301037B6 (cs) * 2007-09-06 2009-10-21 Vysoká škola chemicko-technologická v Praze Amidové konjugáty steroidních a žlucových kyselin s D-glukosaminem a zpusob jejich prípravy
AU2008340354B2 (en) 2007-12-04 2014-04-17 Alnylam Pharmaceuticals, Inc. Folate-iRNA conjugates
EP4074344A1 (en) 2007-12-04 2022-10-19 Arbutus Biopharma Corporation Targeting lipids
US20100021538A1 (en) * 2008-02-29 2010-01-28 Youngro Byun Pharmaceutical compositions containing heparin derivatives
EP3604533A1 (en) 2008-04-11 2020-02-05 Arbutus Biopharma Corporation Site-specific delivery of nucleic acids by combining targeting ligands with endosomolytic components
WO2010062369A2 (en) * 2008-11-03 2010-06-03 Tufts University Methods and compositions for inhibiting clostridium difficile spore germination and outgrowth
US20120157419A1 (en) * 2009-02-02 2012-06-21 Tuvia Gilat Methods and compositions for treating alzheimer's disease
GB2480632A (en) 2010-05-25 2011-11-30 Kythera Biopharmaceuticals Inc Preparation of 12-keto and 12-alpha-hydroxy steroids
CN102115486B (zh) * 2009-12-30 2015-06-03 上海特化医药科技有限公司 一种3-β-花生酰胺基-7α,12α,5β-胆烷-24-羧酸的制备方法
TWI665211B (zh) * 2011-06-16 2019-07-11 美商凱瑟拉生物製藥有限公司 去氧膽酸之組成物及用途及其相關方法
CN105611919A (zh) * 2013-08-08 2016-05-25 盖尔德姆疗法有限公司 包含胆汁酸-脂肪酸缀合物的抗痤疮组合物
CA2930232C (en) * 2013-12-04 2020-09-15 Galmed Research & Development Ltd. Aramchol salts
US11571431B2 (en) 2013-12-04 2023-02-07 Galmed Research And Development Ltd Aramchol salts
CN106413719A (zh) * 2014-06-01 2017-02-15 盖尔梅德研究与发展有限公司 用于治疗脂肪营养不良的脂肪酸胆汁酸缀合物
JOP20200092A1 (ar) 2014-11-10 2017-06-16 Alnylam Pharmaceuticals Inc تركيبات iRNA لفيروس الكبد B (HBV) وطرق لاستخدامها
US10849911B2 (en) 2015-06-10 2020-12-01 Galmed Research And Development Ltd. Low dose compositions of Aramachol salts
IL243707A0 (en) 2016-01-20 2016-05-01 Galmed Res And Dev Ltd Treatment to regulate the microbiota in the intestine
CN106496300B (zh) * 2016-10-19 2018-05-18 上海博志研新药物技术有限公司 花生胆酸及其中间体的制备方法
US11197870B2 (en) 2016-11-10 2021-12-14 Galmed Research And Development Ltd Treatment for hepatic fibrosis
MX2019005531A (es) * 2016-11-10 2019-09-16 Galmed Res And Development Ltd Inhibicion de la fibrosis en pacientes con enfermedad de higado graso no alcoholico.
US11324820B2 (en) 2017-04-18 2022-05-10 Alnylam Pharmaceuticals, Inc. Methods for the treatment of subjects having a hepatitis b virus (HBV) infection
US11136347B2 (en) 2017-06-07 2021-10-05 Crystal Pharmaceutical (Suzhou) Co., Ltd. Crystalline forms of a fatty acid bile acid conjugate, preparation method thereof and use thereof
MX2021001056A (es) 2018-08-13 2021-04-12 Alnylam Pharmaceuticals Inc Composiciones de agente de acido ribonucleico bicatenario (arnbc) de virus de la hepatitis b (vhb) y metodos de uso de las mismas.
IT202000000328A1 (it) 2020-01-10 2021-07-10 Ice S P A Metodo di preparazione dell'aramchol
CN114524857B (zh) * 2022-02-22 2023-06-30 中国科学院微生物研究所 胆酸衍生物及其应用
CN116687850A (zh) 2022-02-24 2023-09-05 甘莱制药有限公司 包含环状膦酸酯化合物的药物组合物及其制备方法与用途
WO2023227723A1 (en) * 2022-05-26 2023-11-30 Pharmazell Gmbh An improved process for the preparation of aramchol and salts thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3856953A (en) * 1973-05-15 1974-12-24 Intellectual Property Dev Corp Method of treating fatty liver
IT1167478B (it) * 1981-07-24 1987-05-13 Carlo Scolastico Derivati dell'acido ursodesossicolico
IT1167479B (it) * 1981-07-24 1987-05-13 Carlo Scolastico Derivati dell'acido chenodesossicolico
DE3930696A1 (de) * 1989-09-14 1991-03-28 Hoechst Ag Gallensaeurederivate, verfahren zu ihrer herstellung, verwendung als arzneimittel
IL123998A (en) * 1998-04-08 2004-09-27 Galmed Int Ltd Conjugates of bile salts and pharmaceutical preparations containing them
DE19824123A1 (de) * 1998-05-29 1999-12-02 Hoechst Marion Roussel De Gmbh Gallensäurederivat, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung

Also Published As

Publication number Publication date
NO20004998D0 (no) 2000-10-04
EP1071702A1 (en) 2001-01-31
PL199271B1 (pl) 2008-09-30
WO1999052932A1 (en) 1999-10-21
US20020091111A1 (en) 2002-07-11
BR9909908B1 (pt) 2014-03-18
ID26042A (id) 2000-11-16
EP1071702B1 (en) 2002-08-28
CA2325933A1 (en) 1999-10-21
CN100386339C (zh) 2008-05-07
US6384024B1 (en) 2002-05-07
BR9909908A (pt) 2000-12-26
HUP0101653A2 (hu) 2001-12-28
JP2002511482A (ja) 2002-04-16
EA003392B1 (ru) 2003-04-24
HU229513B1 (en) 2014-01-28
CN1296492A (zh) 2001-05-23
NZ507309A (en) 2003-06-30
NO20004998L (no) 2000-12-06
US6589946B2 (en) 2003-07-08
KR20010042342A (ko) 2001-05-25
AU742944B2 (en) 2002-01-17
DK1071702T3 (da) 2002-12-30
UA70318C2 (uk) 2004-10-15
ATE222923T1 (de) 2002-09-15
DE69902647T2 (de) 2003-04-24
CZ300824B6 (cs) 2009-08-19
DE69902647D1 (de) 2002-10-02
HUP0101653A3 (en) 2002-02-28
SI1071702T1 (en) 2003-04-30
US6395722B1 (en) 2002-05-28
IL123998A (en) 2004-09-27
KR100615560B1 (ko) 2006-08-25
NO316875B1 (no) 2004-06-07
AU3051599A (en) 1999-11-01
TR200002876T2 (tr) 2000-12-21
JP5031942B2 (ja) 2012-09-26
PL343360A1 (en) 2001-08-13
BRPI9909908B8 (pt) 2021-05-25
CZ20003625A3 (cs) 2001-01-17
ES2183526T3 (es) 2003-03-16
CA2325933C (en) 2008-06-10
EA200000888A1 (ru) 2001-04-23

Similar Documents

Publication Publication Date Title
PT1071702E (pt) Derivados de acidos gordos de acidos biliares e derivados de acidos biliares
EP1334719A3 (en) Pentafluorobenzenesulfonamides and analogs
HK1021699A1 (en) Pentafluorobenzenesulfonamides and analogs.
MXPA03009553A (es) Uso de acido biliar o conjugados de acidos grasos de sales biliares.
IT1304501B1 (it) Uso di derivati di acidi biliari coniugati con complessi metallicicome "blood pool agents" per l'indagine diagnostica tramite risonanza
CY1105591T1 (el) Αναστολεις για συνθαση του 20-ηετε
BR0008437A (pt) Inibidores esteróides de sulfatase e métodos parafabricação e uso dos mesmos
DK0613687T3 (da) Anvendelse af pregnanderivat til behandling af tumorer
HUP0301257A2 (hu) Szubsztituált akriloil-disztamicin-származékokat és topoizomeráz I és II inhibitorokat tartalmazó kombinált tumorellenes kompozíciók
MX9707046A (es) Composiciones que comprenden nicotinilalanina y un inhibidor de conjugacion de glicina o vitamina b6.
YU19302A (sh) 4-benzilaminohinolin konjugovan žučnom kiselinom i njegovi heteroanalozi, postupak za njihovu proizvodnju, lekovi koji sadrže ta jedinjenja i njihova primena
HUP0301234A2 (hu) Szubsztituált akriloil-disztamicin-származékokat és alkilezőszereket tartalmazó kombinált tumorellenes kompozíciók
ATE254460T1 (de) Anhydrovinblastin zur behandlung von krebs
CA2215319A1 (en) Compositions comprising nicotinylalanine and an inhibitor of glycine conjugation or vitamin b6